Buy Stocks Easy | About Us
April 23, 2021
Buy Stocks Easy | Online Stocks

SLNO


Buy Soleno Therapeutics, Inc. Stock (symbol: SLNO) Easy Online

Company Name: Soleno Therapeutics, Inc.

Symbol: SLNO

Sector: Health Care

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus

IPO: 2014

SLNO Current Share Price

Today's SLNO ( Soleno Therapeutics, Inc. ) opening price: $1.7000

Yesterday's SLNO ( Soleno Therapeutics, Inc. ) closing price: $1.7100

Soleno Therapeutics, Inc. Stock ( symbol: SLNO ) Price Chart since IPO (2014):

12 Months Soleno Therapeutics, Inc. Stock ( symbol: SLNO ) Price Chart

Popular Questions about Soleno Therapeutics, Inc. Public Stock ( SLNO )

A: Soleno Therapeutics, Inc. stock symbol (also called stock or share ticker) is SLNO

A: Soleno Therapeutics, Inc. IPO (Initial Public Offering) took place on 2014

A: Soleno Therapeutics, Inc.'s stock (SLNO symbol) price at ther IPO (initial Public Offering) was $1.7000

Q: Is SLNO stock worth buying at the moment?

A: The SLNO stock performance since 2019 are rather disappointing. If you had bought 1 share of Soleno Therapeutics, Inc. stock (symbol: SLNO) at the beginning of 2019, at the opening share price of $1.7700, you would be left with exactly $1.7000 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Soleno Therapeutics, Inc. Stock Easy Online

Soleno Therapeutics, Inc. Stock Ticker Price Chart since IPO:





Soleno Therapeutics, Inc. Stock Price Yesterday



 


Soleno Therapeutics, Inc. Stock Price – Last Week




 


Soleno Therapeutics, Inc. Stock Price – Last Month




 


Soleno Therapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/25/1935903/0/en/Soleno-Therapeutics-Announces-Closing-of-15-4-Million-Public-Offering-of-Common-Stock.html
                            

                                
Soleno Therapeutics Announces Closing of $15.4 Million Public Offering of Common Stock

                                
                                
REDWOOD CITY, Calif., Oct.  25, 2019  (GLOBE NEWSWIRE) -- Soleno Th...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/22/1933602/0/en/Soleno-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html
                            

                                
Soleno Therapeutics Announces Proposed Public Offering of Common Stock

                                
                                
REDWOOD CITY, Calif., Oct.  22, 2019  (GLOBE NEWSWIRE) -- Soleno Th...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/02/1924013/0/en/Soleno-Therapeutics-Announces-Positive-Outcome-from-Second-Planned-Data-Safety-Monitoring-Board-Review-of-Phase-III-DESTINY-PWS-Clinical-Trial-of-DCCR-in-Prader-Willi-Syndrome.html
                            

                                
Soleno Therapeutics Announces Positive Outcome from Second Planned Data Safety Monitoring Board Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi Syndrome

                                
                                
REDWOOD CITY, Calif., Oct.  02, 2019  (GLOBE NEWSWIRE) -- Soleno Th...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/24/1919866/0/en/Soleno-Therapeutics-Announces-Publication-of-Results-from-Previously-Completed-Phase-II-Trial-of-DCCR-for-Treatment-of-Prader-Willi-Syndrome.html
                            

                                
Soleno Therapeutics Announces Publication of Results from Previously Completed Phase II Trial of DCCR for Treatment of Prader-Willi Syndrome

                                
                                
Data Published for First Time in Peer-Reviewed Journal Data Publish...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/19/1917922/0/en/Soleno-Therapeutics-to-Participate-in-the-Oppenheimer-Fall-Summit-Focused-on-Specialty-Pharma-Rare-Disease-Companies.html
                            

                                
Soleno Therapeutics to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease Companies

                                
                                
REDWOOD CITY, Calif., Sept.  19, 2019  (GLOBE NEWSWIRE) -- Soleno T...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/420398/will-capnia-to-surge-higher
                            

                                
Will Capnia to Surge Higher?

                                
                                
As of late, it has definitely been a great time to be an investor C...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/25/1935903/0/en/Soleno-Therapeutics-Announces-Closing-of-15-4-Million-Public-Offering-of-Common-Stock.html
                            

                                
Soleno Therapeutics Announces Closing of $15.4 Million Public Offering of Common Stock

                                
                                
REDWOOD CITY, Calif., Oct.  25, 2019  (GLOBE NEWSWIRE) -- Soleno Th...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/22/1933602/0/en/Soleno-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html
                            

                                
Soleno Therapeutics Announces Proposed Public Offering of Common Stock

                                
                                
REDWOOD CITY, Calif., Oct.  22, 2019  (GLOBE NEWSWIRE) -- Soleno Th...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/02/1924013/0/en/Soleno-Therapeutics-Announces-Positive-Outcome-from-Second-Planned-Data-Safety-Monitoring-Board-Review-of-Phase-III-DESTINY-PWS-Clinical-Trial-of-DCCR-in-Prader-Willi-Syndrome.html
                            

                                
Soleno Therapeutics Announces Positive Outcome from Second Planned Data Safety Monitoring Board Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi Syndrome

                                
                                
REDWOOD CITY, Calif., Oct.  02, 2019  (GLOBE NEWSWIRE) -- Soleno Th...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/24/1919866/0/en/Soleno-Therapeutics-Announces-Publication-of-Results-from-Previously-Completed-Phase-II-Trial-of-DCCR-for-Treatment-of-Prader-Willi-Syndrome.html
                            

                                
Soleno Therapeutics Announces Publication of Results from Previously Completed Phase II Trial of DCCR for Treatment of Prader-Willi Syndrome

                                
                                
Data Published for First Time in Peer-Reviewed Journal Data Publish...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/19/1917922/0/en/Soleno-Therapeutics-to-Participate-in-the-Oppenheimer-Fall-Summit-Focused-on-Specialty-Pharma-Rare-Disease-Companies.html
                            

                                
Soleno Therapeutics to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease Companies

                                
                                
REDWOOD CITY, Calif., Sept.  19, 2019  (GLOBE NEWSWIRE) -- Soleno T...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/420398/will-capnia-to-surge-higher
                            

                                
Will Capnia to Surge Higher?

                                
                                
As of late, it has definitely been a great time to be an investor C...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.